Breast Neoplasms: all 12,820 studies
Page 78 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer PatientsCompletedNCT03860740
- Follow-up in Early and Locally Advanced Breast Cancer PatientsCompletedNCT03859453
- Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBCTerminatedNCT03858972Phase 2
- A Pilot Study on Use of Liquid Crystal Contact Thermography to Detect Early Breast CancerCompletedNCT03858738
- 'ADVANCE' (A Pilot Trial)Active, not recruitingNCT03858322Phase 1
- Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast CancerCompletedNCT03856372Not applicable
- Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast CancerStatus unknownNCT03855423Not applicable
- A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)Status unknownNCT03855358Phase 1
- WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 InhibitorCompletedNCT03854903Phase 1
- Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast CancerCompletedNCT03851497
- Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE StudyTerminatedNCT03850171Not applicable
- A Web-Based Tool to Improve Breast Cancer SurvivorshipCompletedNCT03849573Not applicable
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast CancerStatus unknownNCT03847818Not applicable
- Effect of Preoperative Curcumin in Breast Cancer PatientsStatus unknownNCT03847623Not applicable
- Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone MetastasisCompletedNCT03847220
- KN026 in Patients With HER2 Expressing Breast Cancer and Gastric CancerStatus unknownNCT03847168Phase 1
- Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer SurvivorsCompletedNCT03846999
- Tucatinib + Abemaciclib + Herceptin for HER2+ MBCWithdrawnNCT03846583Phase 1
- Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CTActive, not recruitingNCT03846167
- A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsActive, not recruitingNCT03845166Phase 1
- Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given TamoxifenCompletedNCT03844685Phase 2
- The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast CancerCompletedNCT03843346
- Clinical Application of CTC in Operable Breast Cancer PatientsStatus unknownNCT03842176
- Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast CancerWithdrawnNCT03841747Phase 2
- Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic IndicationCompletedNCT03838549Not applicable
- Intraoperative Electron Radiotherapy for Low-risk Early Breast CancerSuspendedNCT03838419Not applicable
- Acupuncture for Joint Symptoms in Patients With Breast CancerTerminatedNCT03836872Not applicable
- Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast CancerStatus unknownNCT03835897
- Living Well After Breast SurgeryCompletedNCT03834532Not applicable
- Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer TreatmentCompletedNCT03833726Not applicable
- Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block FailureCompletedNCT03832920
- Assessing the Immunogenicity of pING-hHER3FLActive, not recruitingNCT03832855Phase 1
- Evaluating and Following Breast Cancer Patients in a Better WayStatus unknownNCT03831308
- Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant SettingActive, not recruitingNCT03831178Phase 2
- Physical and Psychological Effects of Different Temperature-controlled Breast Prostheses on Patients With Breast CancerCompletedNCT03830294Not applicable
- An Enhanced Artificial Intelligence Breast MRI Interpretation SystemStatus unknownNCT03829423Not applicable
- Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)CompletedNCT03829306
- PILATES METHOD ON THE UPPER LIMBS FUNCTIONALITYCompletedNCT03826979Not applicable
- Every Day Counts: A Lifestyle Program for Women With Metastatic Breast CancerCompletedNCT03824145Not applicable
- A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant TherapyActive, not recruitingNCT03822312Not applicable
- Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant ChemotherapyStatus unknownNCT03821454Not applicable
- Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 StudyActive, not recruitingNCT03820063Phase 2
- Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -CompletedNCT03819010Phase 2
- Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual DiseaseActive, not recruitingNCT03818685Phase 2
- Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is FeasibleActive, not recruitingNCT03818100
- Elevate! : An Elderly Breast Cancer Cohort StudyActive, not recruitingNCT03818087
- Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After TreatmentCompletedNCT03817814
- Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer SurgeryCompletedNCT03817359Not applicable
- Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)TerminatedNCT03816839Phase 1
- Circulating Osteocalcin-positive Cells in Breast Cancer Bone MetastasisStatus unknownNCT03814811
- Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative BreastActive, not recruitingNCT03812393Phase 2
- A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast CancerWithdrawnNCT03811418Phase 3
- Comparison of Erector Spinae Plane Block With PECS II Block in Patients Undergoing Breast Cancer SurgeryWithdrawnNCT03811262Not applicable
- PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)CompletedNCT03809988Phase 2
- Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain MetastasesCompletedNCT03807765Phase 1
- Enhancing Shared Decision-Making in Breast CancerCompletedNCT03806738Not applicable
- FUSCC Refractory TNBC Umbrella (FUTURE)Status unknownNCT03805399Phase 1/2
- Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community SettingWithdrawnNCT03804255
- A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast CancerWithdrawnNCT03803761Phase 1/2
- Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast CancerCompletedNCT03802604Early Phase 1
- Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse RiskCompletedNCT03800355
- Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast CancerStatus unknownNCT03799692Phase 4
- Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast CancerStatus unknownNCT03799679Phase 4
- Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast CancerStatus unknownNCT03797248
- Limited Versus No-limited Shoulder Movement in Breast Cancer SurgeryCompletedNCT03796845Not applicable
- Diet Restriction and Exercise-induced Adaptations in Metastatic Breast CancerCompletedNCT03795493Not applicable
- Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast CancerActive, not recruitingNCT03795246Not applicable
- Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer PatientsTerminatedNCT03795012Phase 2
- A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT03794596Phase 2
- Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in ChinaStatus unknownNCT03792529
- Light-CT in the Diagnosis of Breast Tumor and Lymph NodeStatus unknownNCT03791853
- The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADSCompletedNCT03791840
- Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele FormationTerminatedNCT03791736Not applicable
- Assessment of Feasibility and Acceptability of Personalized Breast Cancer ScreeningCompletedNCT03791008Not applicable
- Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast CancersStatus unknownNCT03790813Not applicable
- A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical ActivityCompletedNCT03789877Not applicable
- Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast CancerStatus unknownNCT03789851Not applicable
- Vaccination With Flt3L, Radiation, and Poly-ICLCCompletedNCT03789097Phase 1/2
- BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of TreatmentCompletedNCT03789019Phase 2
- Persistant Organics Pollutants in Breast Cancer.CompletedNCT03788187Not applicable
- Intratumoral TriMix Injections in Early Breast Cancer PatientsStatus unknownNCT03788083Phase 1
- Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise ProgramCompletedNCT03787966Not applicable
- Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast CancerStatus unknownNCT03786575Not applicable
- Activity Program During Aromatase Inhibitor TherapyCompletedNCT03786198Not applicable
- Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast CancerStatus unknownNCT03785704Phase 2
- Distress Reduction by Activity Tracking and Activity Enhancement by Mobile Support Group in OncologyCompletedNCT03783481Not applicable
- Pre- or Postoperative Accelerated RadiotherapyCompletedNCT03783364Not applicable
- The Effects of Anesthetics on Persistent Pain Following Breast Cancer SurgeryCompletedNCT03782896
- Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationCompletedNCT03781063Phase 2
- Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer CareCompletedNCT03780491Not applicable
- Acute Exercise Intervention in Breast Cancer SurvivorsTerminatedNCT03779867Not applicable
- GENe EXpression After Regional or General ANesthesia in Patients Undergoing Breast Cancer SurgeryStatus unknownNCT03779685Not applicable
- miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant TreatmentStatus unknownNCT03779022
- Emotional Evaluation and Reconstructed Breast SatisfactionStatus unknownNCT03777852Not applicable
- A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBCSuspendedNCT03777579Phase 3
- Awareness About Breast Cancer ScreeningCompletedNCT03777397
- Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast CancerStatus unknownNCT03775928Phase 2
- A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsCompletedNCT03775850Phase 1
- Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerStatus unknownNCT03775525Phase 1
- Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast CancerActive, not recruitingNCT03772353Phase 1/2